what type of glp is tirzepatide Explained: The Future Weight Management Use of the dual GIP/GLP-1
Description
Tirzepatide, Eli Lillys dual GIP/GLP-1 agonist, has a primary patent estate running into the early 2030s, providing a longer runway before generic entry considerations become commercially pressing
The graphical abstract was created using BioRender
To manage these: Stick to bland, smaller meals
Our lawyers provide quality and caring legal services to people like you
Due to this unique dual activity property, it is also referred to as twincretin
